These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14600507)

  • 1. Abnormal contingent negative variation in HIV patients receiving antiretroviral therapy.
    Chao LL; Cardenas VA; Meyerhoff DJ; Rothlind JC; Flenniken DL; Lindgren JA; Weiner MW
    Neuroreport; 2003 Nov; 14(16):2111-5. PubMed ID: 14600507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent effects of HIV, aging, and HAART on brain volumetric measures.
    Ances BM; Ortega M; Vaida F; Heaps J; Paul R
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):469-77. PubMed ID: 22269799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensorimotor dysfunction in HIV/AIDS: effects of antiretroviral treatment and comorbid psychiatric disorders.
    Bauer LO; Ceballos NA; Shanley JD; Wolfson LI
    AIDS; 2005 Mar; 19(5):495-502. PubMed ID: 15764855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrophic brain signatures of mild forms of neurocognitive impairment in virally suppressed HIV infection.
    Nichols MJ; Gates TM; Soares JR; Moffat KJ; Rae CD; Brew BJ; Cysique LA
    AIDS; 2019 Jan; 33(1):55-66. PubMed ID: 30325766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human immunodeficiency virus infection in the CNS and decreased dopamine availability: relationship with neuropsychological performance.
    Kumar AM; Ownby RL; Waldrop-Valverde D; Fernandez B; Kumar M
    J Neurovirol; 2011 Feb; 17(1):26-40. PubMed ID: 21165787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Effect of Central Nervous System Penetration Effectiveness of Highly Active Antiretroviral Therapy on Neuropsychological Performance and Neuroimaging in HIV Infected Individuals.
    Baker LM; Paul RH; Heaps-Woodruff JM; Chang JY; Ortega M; Margolin Z; Usher C; Basco B; Cooley S; Ances BM
    J Neuroimmune Pharmacol; 2015 Sep; 10(3):487-92. PubMed ID: 25900078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Brain Structure Changes and Cognitive Function With Combination Antiretroviral Therapy in HIV-Positive Individuals.
    Sanford R; Fellows LK; Ances BM; Collins DL
    JAMA Neurol; 2018 Jan; 75(1):72-79. PubMed ID: 29131878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERP evidence of impaired central nervous system function in virally suppressed HIV patients on antiretroviral therapy.
    Chao LL; Lindgren JA; Flenniken DL; Weiner MW
    Clin Neurophysiol; 2004 Jul; 115(7):1583-91. PubMed ID: 15203059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evoked Potentials and Memory/Cognition Tests Validate Brain Atrophy as Measured by 3T MRI (NeuroQuant) in Cognitively Impaired Patients.
    Braverman ER; Blum K; Hussman KL; Han D; Dushaj K; Li M; Marin G; Badgaiyan RD; Smayda R; Gold MS
    PLoS One; 2015; 10(8):e0133609. PubMed ID: 26244349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral metabolite abnormalities in human immunodeficiency virus are associated with cortical and subcortical volumes.
    Cohen RA; Harezlak J; Gongvatana A; Buchthal S; Schifitto G; Clark U; Paul R; Taylor M; Thompson P; Tate D; Alger J; Brown M; Zhong J; Campbell T; Singer E; Daar E; McMahon D; Tso Y; Yiannoutsos CT; Navia B;
    J Neurovirol; 2010 Nov; 16(6):435-44. PubMed ID: 20961212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive functioning, wellbeing and brain correlates in HIV-1 infected patients on long-term combination antiretroviral therapy.
    Janssen MA; Meulenbroek O; Steens SC; Góraj B; Bosch M; Koopmans PP; Kessels RP
    AIDS; 2015 Oct; 29(16):2139-48. PubMed ID: 26544578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort.
    Robertson KR; Su Z; Margolis DM; Krambrink A; Havlir DV; Evans S; Skiest DJ;
    Neurology; 2010 Apr; 74(16):1260-6. PubMed ID: 20237308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalamic atrophy predicts cognitive impairment in relapsing remitting multiple sclerosis. Effect on instrumental activities of daily living and employment status.
    Papathanasiou A; Messinis L; Zampakis P; Panagiotakis G; Gourzis P; Georgiou V; Papathanasopoulos P
    J Neurol Sci; 2015 Nov; 358(1-2):236-42. PubMed ID: 26359854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eyes and hands oscillation in HIV-associated neurocognitive disorder: A case report.
    Sugimoto A; Yazawa S; Nakao K; Ochiai E; Suzuki Y; Iwao K; Okayama A; Ohi T; Tsuruta K
    J Neurol Sci; 2019 Sep; 404():112-114. PubMed ID: 31362160
    [No Abstract]   [Full Text] [Related]  

  • 15. Regionally Specific Brain Volumetric and Cortical Thickness Changes in HIV-Infected Patients in the HAART Era.
    Sanford R; Fernandez Cruz AL; Scott SC; Mayo NE; Fellows LK; Ances BM; Collins DL
    J Acquir Immune Defic Syndr; 2017 Apr; 74(5):563-570. PubMed ID: 28129254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Putamen hypertrophy in nondemented patients with human immunodeficiency virus infection and cognitive compromise.
    Castelo JM; Courtney MG; Melrose RJ; Stern CE
    Arch Neurol; 2007 Sep; 64(9):1275-80. PubMed ID: 17846265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural gray and white matter changes in patients with HIV.
    Küper M; Rabe K; Esser S; Gizewski ER; Husstedt IW; Maschke M; Obermann M
    J Neurol; 2011 Jun; 258(6):1066-75. PubMed ID: 21207051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus has similar effects on brain volumetrics and cognition in males and females.
    Behrman-Lay AM; Paul RH; Heaps-Woodruff J; Baker LM; Usher C; Ances BM
    J Neurovirol; 2016 Feb; 22(1):93-103. PubMed ID: 26306688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of comorbidity burden and age on brain integrity in HIV.
    Saloner R; Heaton RK; Campbell LM; Chen A; Franklin D; Ellis RJ; Collier AC; Marra C; Clifford DB; Gelman B; Sacktor N; Morgello S; McCutchan JA; Letendre S; Grant I; Fennema-Notestine C;
    AIDS; 2019 Jun; 33(7):1175-1185. PubMed ID: 30870195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcortical brain atrophy persists even in HAART-regulated HIV disease.
    Becker JT; Sanders J; Madsen SK; Ragin A; Kingsley L; Maruca V; Cohen B; Goodkin K; Martin E; Miller EN; Sacktor N; Alger JR; Barker PB; Saharan P; Carmichael OT; Thompson PM;
    Brain Imaging Behav; 2011 Jun; 5(2):77-85. PubMed ID: 21264551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.